Alliance and other revenues — Total Revenues
Bristol-Myers Squibb Alliance and other revenues — Total Revenues increased by 3.3% to $372.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.0%, from $409.00M to $372.00M. Over 3 years (FY 2021 to FY 2024), Alliance and other revenues — Total Revenues shows an upward trend with a 4.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful commercialization of partnered assets or higher royalty income, while a decrease may indicate expiring patents or reduced performance of co-marketed products.
Detailed definition
This metric represents revenue generated from collaborative arrangements, profit-sharing agreements, and royalty streams...
Peer comparison
Peer pharmaceutical companies often report this as 'Collaboration Revenue' or 'Other Operating Income,' though the composition varies based on the specific nature of licensing and co-promotion agreements.
bmy_segment_alliance_and_other_revenues_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $332.50M | $332.50M | $332.50M | $340.00M | $402.00M | $405.00M | $341.00M | $289.00M | $309.00M | $321.00M | $309.00M | $306.00M | $276.00M | $409.00M | $531.00M | $315.00M | $360.00M | $372.00M |
| QoQ Change | — | +0.0% | +0.0% | +2.3% | +18.2% | +0.7% | -15.8% | -15.2% | +6.9% | +3.9% | -3.7% | -1.0% | -9.8% | +48.2% | +29.8% | -40.7% | +14.3% | +3.3% |
| YoY Change | — | — | — | — | +20.9% | +21.8% | +2.6% | -15.0% | -23.1% | -20.7% | -9.4% | +5.9% | -10.7% | +27.4% | +71.8% | +2.9% | +30.4% | -9.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's alliance and other revenues — total revenues?
- Bristol-Myers Squibb (BMY) reported alliance and other revenues — total revenues of $372.00M in Q3 2025.
- How has Bristol-Myers Squibb's alliance and other revenues — total revenues changed year-over-year?
- Bristol-Myers Squibb's alliance and other revenues — total revenues decreased by 9.0% year-over-year, from $409.00M to $372.00M.
- What is the long-term trend for Bristol-Myers Squibb's alliance and other revenues — total revenues?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's alliance and other revenues — total revenues has grown at a 4.6% compound annual growth rate (CAGR), from $1.33B to $1.52B.
- What does alliance and other revenues — total revenues mean?
- Revenue earned from collaborative partnerships, profit-sharing, and royalty agreements with other companies.